Sabirin, Samira .
HRN: 21-89-09 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/12/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
09/12/2022
09/19/2022
PO
7.5ml
Q8hours
Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes